Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers

Juvenile Idiopathic Arthritis

Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience

Rheumatology (Oxford).

Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J

doi: 10.1093/rheumatology/keaa118.

Juvenile Idiopathic Arthritis

Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort

Arthritis Care Res (Hoboken).

Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Toftedal P, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T, Nordic Study Group of Pediatric Rheumatology (NoSPeR)

doi: 10.1002/acr.23853.

PsoriasisJuvenile Idiopathic ArthritisPsoriatic Arthritis

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study

Pediatr Rheumatol Online J.

Ekelund M, Aalto K, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L; Nordic Study Group of Pediatric Rheumatology (NoSPeR)

doi: 10.1186/s12969-017-0145-5.

Further Publications Dermatology

Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study

JAMA Dermatol

Kridin K, Brüggen MC, Chua SL, Bygum A, Walsh S, Nägeli MC, Kucinskiene V, French L, Tétart F, Didona B, Milpied B, Ranki A, Salavastru C, Brezinová E, Divani-Patel S, Lorentzen T, Nagel JL, Valiukeviciene S, Karpaviciute V, Tiplica GS, Oppel E, Oschmann A, de Prost N, Vorobyev A, Ingen-Housz-Oro S

doi: 10.1001/jamadermatol.2021.3154

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

Arthritis Res Ther.

Campanilho-Marques R, Deakin CT, Simou S, Papadopoulou C, Wedderburn LR, Pilkington CA, Juvenile Dermatomyositis Research Group (JDRG).

doi: 10.1186/s13075-020-02164-5.

Juvenile Idiopathic ArthritisSystemic Sclerosis

CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis

Rheumatology (Oxford).

McErlane F, Armitt G, Cobb J, Bailey K, Cleary G, Douglas S, Lunt L, Rashid A, Sampath S, Shoop-Worrall S, Smith N, Foster H, Thomson W

doi: 10.1093/rheumatology/

Further Publications Rheumatology

Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis

J Rheumatol

Concha S, Morales PS, Talesnik E, Borzutzky A

doi: 10.3899/jrheum.210011

Juvenile Idiopathic Arthritis

Long term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition

Arthritis Rheumatol.

Shoop-Worrall SJ, Verstappen SM, McDonagh JE, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL

doi: 10.1002/art.40519.

Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry

Clin Rheumatol.

Challa D, Crowson CS, Niewold TB, Reed AM; CARRA Legacy Registry Investigators

doi: 10.1007/s10067-017-3901-5.

Related content

Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience

Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study

Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis

Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis

Long term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition

Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry